SABRIL (vigabatrin) is a prescription medication used with various other therapies in grownups and youngsters 2 years old and older with refractory complicated partial seizures (CPS) that have not responded well enough to numerous other therapies and if the feasible advantages surpass the risk of vision loss.
It is suggested that your doctor test your (or your youngster's) vision prior to or within 4 weeks after starting SABRIL and a minimum of every 3 months during therapy till SABRIL is stopped. Inform your healthcare provider if you or your child have any type of side effect that bothers you or that does not disappear.
Tell your doctor if you are expectant or intend to obtain expectant. If vision testing can not be done, your doctor might proceed prescribing SABRIL, but will not be able to watch for any kind of vision loss. If vision examinations are refrained routinely, your healthcare provider may stop suggesting SABRIL for you (or your child).